MIRA
INFORM REPORT
|
Report Date : |
28.03.2007 |
IDENTIFICATION
DETAILS
|
Name : |
CLINIRX RESEARCH PRIVATE LIMITED |
|
|
|
|
Registered Office : |
7, Council House Street, Kolkata – 700001, West Bengal |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as on) : |
31.03.2006 |
|
|
|
|
Date of Incorporation : |
07.05.2004 |
|
|
|
|
Com. Reg. No.: |
21-98498 |
|
|
|
|
CIN No.: [Company
Identification No.] |
U85110WB2004PTC098498 |
|
|
|
|
TAN No.: [Tax
Deduction & Collection Account No.] |
DELC07635F |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business : |
Company is engaged in full service contract clinical research
organization. |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 88000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a
well-established and reputed company having satisfactory track. Directors are
reported as experienced and respectable businessmen. Trade relations are reported
as fair. Business is active. Payments are usually correct and as per
commitments. The company can be considered normal for business dealings at usual trade terms and conditions. |
LOCATIONS
|
Registered Office : |
7, Council House Street, Kolkata – 700001, West Bengal, India |
|
Tel. No.: |
91-33-22484198 |
|
Fax No.: |
91-33-22481641 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Corporate Office : |
8/7
F DLF Phase I, Qutub Enclave, Gurgaon- 122002, Haryana, INDIA |
|
Tel. No.: |
91-124-4559 600 |
|
Fax No.: |
91-124-4104 203 |
|
E-Mail : |
DIRECTORS
|
Name : |
Mr. Sujit Kumar Mukhrjee |
|
Designation : |
Director |
|
Address : |
171, Abhinav Apartments, B-12, Vandhana Enclave, Delhi – 110096, India
|
|
Date of Birth/Age : |
21.01.1951 |
|
Date of Appointment : |
07.05.2004 |
|
|
|
|
Name : |
Dr. Ravindra Bhaskar Ghooi |
|
Designation : |
Director |
|
Address : |
D 9/9, 1st Floor, DLF Exclusive Floor, DLF City Phase – 5,
Gurgaon – 122002, Haryana, India |
|
Date of Birth/Age : |
02.07.1950 |
|
Date of Appointment : |
07.05.2004 |
MAJOR SHAREHOLDERS
/ SHAREHOLDING PATTERN
|
Names of Shareholders |
|
No. of Shares |
|
Param Shubham Vanijya Limited |
|
80000 |
|
Nav Bharat Vanijya Limited |
|
60000 |
|
Juggilal Kamlapati Udyog Limited |
|
60000 |
|
BMF Beltings Limited |
|
1000000 |
|
Param Shubham Vanijya Limited |
|
400000 |
|
Nav Bharat Vanijya Limited |
|
300000 |
|
Juggilal Kamlapari Udyog Limited |
|
300000 |
|
Total |
|
2200000 |
|
Category |
|
Percentage of
Holding |
|
Bodies corporate |
|
100.00 % |
BUSINESS DETAILS
|
Line of Business : |
|
|
|
|
|
Products : |
|
GENERAL
INFORMATION
|
No. of Employees : |
Company is engaged in full service contract clinical research
organization. |
|
|
|
|
Bankers : |
Not Available |
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
S. R. Batliboi and Associates Chartered Accountants |
|
Address : |
Ernst and Young Tower, B-26, Qutub Institutional Area, New Delhi –
110016, India |
CAPITAL STRUCTURE
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
500,000 |
Equity Shares |
Rs. 10/- each |
Rs. 5.000 Millions |
|
2,000,000 |
Preference Shares |
Rs. 10/- each |
Rs. 20.000 Millions |
|
|
Total |
|
Rs. 25.000
Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
200,000 |
Equity Shares |
Rs. 10/- each |
Rs. 2.000 Millions |
|
2,000,000 |
Preference Shares |
Rs. 10/- each |
Rs. 20.000 Millions |
|
|
Total |
|
Rs. 22.000
Millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
|
31.03.2006 |
31.03.2005 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
|
22.000 |
12.000 |
|
|
2] Share Application Money |
|
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
|
0.000 |
0.000 |
|
|
4] (Accumulated Losses) |
|
0.000 |
0.000 |
|
|
NETWORTH |
|
22.000 |
12.000 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
|
2.021 |
2.175 |
|
|
2] Unsecured Loans |
|
20.000 |
0.000 |
|
|
TOTAL BORROWING |
|
22.021 |
2.175 |
|
|
DEFERRED TAX LIABILITIES |
|
|
|
|
|
|
|
|
|
|
|
TOTAL |
|
44.021 |
14.175 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
|
8.565 |
3.114 |
|
|
Capital work-in-progress |
|
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
|
0.000 |
0.000 |
|
|
DEFERREX TAX ASSETS |
|
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
|
0.000 |
0.000 |
|
|
Sundry Debtors |
|
5.934 |
1.410 |
|
|
Cash & Bank Balances |
|
7.879 |
6.866 |
|
|
Other Current Assets |
|
0.116 |
0.037 |
|
|
Loans & Advances |
|
8.873 |
0.017 |
|
Total
Current Assets |
|
22.802 |
8.330 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Current Liabilities |
|
14.924 |
2.503 |
|
|
Provisions |
|
0.418 |
0.100 |
|
Total
Current Liabilities |
|
15.342 |
2.603 |
|
|
Net Current Assets |
|
7.460 |
5.727 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
|
27.996 |
5.334 |
|
|
|
|
|
|
|
|
TOTAL |
|
44.021 |
14.175 |
|
KEY RATIOS
|
PARTICULARS |
|
|
31.03.2006 |
31.03.2005 |
|
Debt Equity Ratio (Total Liability/Networth) |
|
|
1.70 |
0.40 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
|
1.49 |
3.20 |
LOCAL AGENCY
FURTHER INFORMATION
CliniRx Research Private Limited is a full service contract clinical research
organization based in India. It is promoted by one of India's leading business
conglomerates, namely the JK Organization, which has been in business
for over a 100 years.
CliniRx
is geared to undertake Clinical Trials - Phase II to Phase IV - covering
varying areas from site feasibility to data management.
High
quality, speed and delivering results to meet the customer's needs are what
epitomize the work ethics at CliniRx. The combined years of experience in the
various areas of operations that our team brings with them ensures results.
Management
Dr. Sumant Khanna
Dr. Sunita Rajadhyaksha
Mr. Khawar Parvez
Dr. Chetan Desai
Mr. Chanderbhan Vasandani
Ms. Seema Sikka
Dr. Arun Gupta
Dr. Rakesh Chugh
Mr. Pankaj Kesherwa
Ms. Pooja Jain
Dr. Venu Madhav
Mr. Yajuvinder Gulati
Mr. Gaurav S Bhagat
Mr. Jiban Gogoi
Mr. Paramjita Mohanty
Mr. Sanjay S Mourya
CMT REPORT (Corruption,
Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts, India Prisons Service,
Interpol, etc.
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE
GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.43.47 |
|
UK Pound |
1 |
Rs.85.36 |
|
Euro |
1 |
Rs.57.89 |
SCORE & RATING
EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
3 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
7 |
|
--PROFITABILIRY |
1~10 |
4 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
5 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
44 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|